Concentra Group Holdings Parent, Inc. (CON)vsFresenius Medical Care Corporation (FMS)
CON
Concentra Group Holdings Parent, Inc.
$25.32
+1.61%
HEALTHCARE · Cap: $3.60B
FMS
Fresenius Medical Care Corporation
$23.39
+0.46%
HEALTHCARE · Cap: $12.67B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 767% more annual revenue ($19.36B vs $2.23B). CON leads profitability with a 8.0% profit margin vs 4.9%. FMS trades at a lower P/E of 12.4x. CON earns a higher WallStSmart Score of 59/100 (C).
CON
Buy59
out of 100
Grade: C
FMS
Buy50
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CON.
Margin of Safety
+68.9%
Fair Value
$77.34
Current Price
$23.39
$53.95 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 42 in profit
Earnings expanding 29.4% YoY
Reasonable price relative to book value
Growing faster than its price suggests
Attractively priced relative to earnings
Areas to Watch
8.0% margin — thin
Weak financial health signals
Distress zone — elevated risk
Elevated debt levels
Grey zone — moderate risk
ROE of 7.1% — below average capital efficiency
4.9% margin — thin
Revenue declined 5.5%
Comparative Analysis Report
WallStSmart ResearchBull Case : CON
The strongest argument for CON centers on Return on Equity, EPS Growth. Revenue growth of 13.7% demonstrates continued momentum.
Bull Case : FMS
The strongest argument for FMS centers on Price/Book, PEG Ratio, P/E Ratio. PEG of 0.84 suggests the stock is reasonably priced for its growth.
Bear Case : CON
The primary concerns for CON are Profit Margin, Piotroski F-Score, Altman Z-Score. Debt-to-equity of 5.00 is elevated, increasing financial risk.
Bear Case : FMS
The primary concerns for FMS are Altman Z-Score, Return on Equity, Profit Margin. Thin 4.9% margins leave little buffer for downturns.
Key Dynamics to Monitor
CON is growing revenue faster at 13.7% — sustainability is the question.
FMS generates stronger free cash flow (37M), providing more financial flexibility.
Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
CON scores higher overall (59/100 vs 50/100) and 13.7% revenue growth. FMS offers better value entry with a 68.9% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Concentra Group Holdings Parent, Inc.
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Concentra Group Holdings Parent, Inc. (Ticker: CON) is a dynamic diversified holding company focused on acquiring and managing businesses in high-growth sectors, including healthcare, technology, and infrastructure. With a strong commitment to operational excellence and innovation, Concentra employs its experienced leadership team to drive portfolio optimization through strategic investments and hands-on management. This proactive approach enables the company to effectively seize emerging trends and opportunities, positioning it as a compelling investment for institutional investors seeking diversification into high-potential markets.
Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?